Eghbali A, Safdari S, Yousefi Roozbahani M, Tavajohi K, Hosseini S
Clin Case Rep. 2024; 12(11):e9583.
PMID: 39559288
PMC: 11570422.
DOI: 10.1002/ccr3.9583.
Singh T, Singh N, Devi K, Meiguilungpou R, Khongsai L, Singh L
Molecules. 2022; 27(21).
PMID: 36364114
PMC: 9654912.
DOI: 10.3390/molecules27217288.
Xu M, Chen Z, Lin B, Zhang S, Qu J
Transl Cancer Res. 2022; 10(9):4033-4046.
PMID: 35116701
PMC: 8797290.
DOI: 10.21037/tcr-21-747.
Wu N, Wei L, Li L, Li F, Yu J, Liu J
Int J Clin Oncol. 2022; 27(3):495-511.
PMID: 35064849
DOI: 10.1007/s10147-021-02098-1.
Xie X, Wang Y, Zhang S, Li J, Yu Z, Ding X
Aging (Albany NY). 2021; 13(2):2959-2981.
PMID: 33472169
PMC: 7880389.
DOI: 10.18632/aging.202446.
Both BRCA1-wild type and -mutant triple-negative breast cancers show sensitivity to the NAE inhibitor MLN4924 which is enhanced upon MLN4924 and cisplatin combination treatment.
Misra S, Zhang X, Wani N, Sizemore S, Ray A
Oncotarget. 2020; 11(8):784-800.
PMID: 32166000
PMC: 7055543.
DOI: 10.18632/oncotarget.27485.
Acid-specific formaldehyde donor is a potential, dual targeting cancer chemotherapeutic/chemo preventive drug for FANC/BRCA-mutant cancer.
Ridpath J, Nakamura J
Genes Environ. 2020; 41:23.
PMID: 31890056
PMC: 6921423.
DOI: 10.1186/s41021-019-0136-5.
DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway.
Bhattacharjee S, Nandi S
Cell Commun Signal. 2017; 15(1):41.
PMID: 29017571
PMC: 5635482.
DOI: 10.1186/s12964-017-0195-9.
Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
Sanders M, Haynes B, Nangia-Makker P, Polin L, Shekhar M
J Biol Chem. 2017; 292(25):10347-10363.
PMID: 28490629
PMC: 5481549.
DOI: 10.1074/jbc.M117.792192.
Fanconi anemia-D1 due to homozygosity for the BRCA2 gene Cypriot founder mutation: A case report.
Loizidou M, Hadjisavvas A, Tanteles G, Spanou-Aristidou E, Kyriacou K, Christophidou-Anastasiadou V
Oncol Lett. 2016; 11(1):471-473.
PMID: 26834852
PMC: 4727152.
DOI: 10.3892/ol.2015.3852.
Spontaneous tumor development in bone marrow-rescued DNA-PKcs(3A/3A) mice due to dysfunction of telomere leading strand deprotection.
Zhang S, Matsunaga S, Lin Y, Sishc B, Shang Z, Sui J
Oncogene. 2015; 35(30):3909-18.
PMID: 26616856
PMC: 4885801.
DOI: 10.1038/onc.2015.459.
Gene-ethanol interactions underlying fetal alcohol spectrum disorders.
McCarthy N, Eberhart J
Cell Mol Life Sci. 2014; 71(14):2699-706.
PMID: 24554057
PMC: 11114006.
DOI: 10.1007/s00018-014-1578-3.
The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.
Paul A, Paul S
Front Biosci (Landmark Ed). 2014; 19(4):605-18.
PMID: 24389207
PMC: 4307936.
DOI: 10.2741/4230.
Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma.
Roe O, Szulkin A, Anderssen E, Flatberg A, Sandeck H, Amundsen T
PLoS One. 2012; 7(8):e40521.
PMID: 22905093
PMC: 3414492.
DOI: 10.1371/journal.pone.0040521.
Regulation of Rev1 by the Fanconi anemia core complex.
Kim H, Yang K, Dejsuphong D, DAndrea A
Nat Struct Mol Biol. 2012; 19(2):164-70.
PMID: 22266823
PMC: 3280818.
DOI: 10.1038/nsmb.2222.
The Fanconi anemia pathway and DNA interstrand cross-link repair.
Su X, Huang J
Protein Cell. 2011; 2(9):704-11.
PMID: 21948210
PMC: 4875268.
DOI: 10.1007/s13238-011-1098-y.
Chemistry and structural biology of DNA damage and biological consequences.
Stone M, Huang H, Brown K, Shanmugam G
Chem Biodivers. 2011; 8(9):1571-615.
PMID: 21922653
PMC: 3714022.
DOI: 10.1002/cbdv.201100033.
Formation of a N2-dG:N2-dG carbinolamine DNA cross-link by the trans-4-hydroxynonenal-derived (6S,8R,11S) 1,N2-dG adduct.
Huang H, Wang H, Kozekova A, Rizzo C, Stone M
J Am Chem Soc. 2011; 133(40):16101-10.
PMID: 21916419
PMC: 3187658.
DOI: 10.1021/ja205145q.
Congenital bone marrow failure in DNA-PKcs mutant mice associated with deficiencies in DNA repair.
Zhang S, Yajima H, Huynh H, Zheng J, Callen E, Chen H
J Cell Biol. 2011; 193(2):295-305.
PMID: 21482716
PMC: 3080267.
DOI: 10.1083/jcb.201009074.
Fanconi anemia: a disorder defective in the DNA damage response.
Kitao H, Takata M
Int J Hematol. 2011; 93(4):417-424.
PMID: 21331524
DOI: 10.1007/s12185-011-0777-z.